This observation will lead an opportunity to optimize such treatment combinations, through future studies evaluating the varied dose-dependency of radiation effects on tumor cell expression of type I interferon, NKG2D ligands, PD-L1, and other markers of tumor cell susceptibility to innate and adaptive anti-tumor immunity. Here, CD274 is linked to neoplasm.